n-benzyladriamycin-14-valerate has been researched along with Cardiomyopathies, Primary in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, C; Hofmann, PA; Lothstein, L; Morrison, RR | 1 |
1 other study(ies) available for n-benzyladriamycin-14-valerate and Cardiomyopathies, Primary
Article | Year |
---|---|
Protection from doxorubicin-induced cardiomyopathy using the modified anthracycline N-benzyladriamycin-14-valerate (AD 198).
Topics: AMP-Activated Protein Kinase Kinases; Animals; Antibiotics, Antineoplastic; Blotting, Western; Calcium; Cardiomyopathies; Cardiotonic Agents; Doxorubicin; Electrophoresis, Polyacrylamide Gel; Indicators and Reagents; Male; Mass Spectrometry; Myocytes, Cardiac; Nitric Oxide Synthase Type II; Phosphorylation; Poly Adenosine Diphosphate Ribose; Protein Kinase C-epsilon; Protein Kinases; Rats; Rats, Wistar | 2010 |